We are live on ! Find out more
PCA

Peddock Capital Advisors Portfolio holdings

AUM $501M
1-Year Est. Return 29.8%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$286M
AUM Growth
+$24.3M
Cap. Flow
+$36.4M
Cap. Flow %
12.71%
Top 10 Hldgs %
41.19%
Holding
161
New
9
Increased
81
Reduced
23
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 17.29%
2 Energy 15.77%
3 Financials 6.76%
4 Healthcare 6.45%
5 Consumer Staples 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAD icon
151
Nuveen Quality Municipal Income Fund
NAD
$2.73B
-22,300
Closed -$338K
NRK icon
152
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$904M
-12,500
Closed -$171K
VGM icon
153
Invesco Trust Investment Grade Municipals
VGM
$552M
-13,300
Closed -$179K
MSPR
154
DELISTED
MSP Recovery Inc
MSPR
-5
Closed -$196K
ADOC
155
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
-19,100
Closed -$191K
AGAC
156
DELISTED
African Gold Acquisition Corp
AGAC
-11,500
Closed -$114K
PSAGU
157
DELISTED
Property Solutions Acquisition Corporation II Units
PSAGU
-12,000
Closed -$118K
RDBX
158
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
-11,200
Closed -$110K
GCAC
159
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
-15,570
Closed -$151K
PTK
160
DELISTED
PTK Acquisition Corp.
PTK
-10,150
Closed -$100K
ALXN
161
DELISTED
Alexion Pharmaceuticals
ALXN
-2,348
Closed -$359K

Similar funds

Peddock Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Peddock Capital Advisors held 161 positions worth $286M, up 9.3% from $262M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Peddock Capital Advisors deployed $36.4M of net new capital in Q2 2021, opening 9 new positions and adding to 81 existing holdings. Its largest new stake was AstraZeneca: 2,474 shares worth $283K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $361K trimmed.

  • Peddock Capital Advisors's largest Q2 2021 buy was AstraZeneca: 2,474 shares worth $283K.
  • Peddock Capital Advisors added most to NVIDIA in Q2 2021, an estimated $33M increase.
  • Peddock Capital Advisors's biggest Q2 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $361K.
  • Peddock Capital Advisors fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $359K.
  • Peddock Capital Advisors's ten largest holdings make up 41% of its $286M portfolio in Q2 2021.
  • Peddock Capital Advisors opened 9 new positions and closed 17 in Q2 2021.
  • Peddock Capital Advisors's portfolio value rose 9.3% quarter-over-quarter to $286M.

Based on Peddock Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.